Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair



Status:Recruiting
Conditions:Chronic Pain, Post-Surgical Pain, Gastrointestinal
Therapuetic Areas:Gastroenterology, Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:April 2014
End Date:June 2017
Contact:Annemarie Dalton, RN, BSN
Email:adalton3@kumc.edu
Phone:913-588-0068

Use our guide to learn which trials are right for you!

The purpose of this study is to learn how well Liposomal Bupivacaine (Exparel™) controls
post-operative pain in patients undergoing both open and laparoscopic (minimally invasive)
abdominal hernia repair surgery.

When a person has surgery, there are a few different standard care options for pain relief.
Anesthetic (numbing) drugs can be used to cause a loss of feeling in or around a wound but
the effect of the numbing medication can be undone.Pain relieving drugs such as
acetaminophen (Tylenol), non-steroidal anti-inflammatory drugs (NSAIDs), and opioid
(narcotic) medications can also be taken by mouth or through a vein in your arm (intravenous
IV.) However, both NSAIDs & Opioid drugs can produce negative side effects such as serious
difficulty breathing, stopping breathing altogether, low blood pressure, nausea, vomiting,
itching, and constipation.

Bupivacaine is one of the commonly used longer-acting numbing medicines (anesthetics). The
effect of Bupivacaine or other anesthetics is limited to usually no more than 12 hours when
injected around the area of the incision during surgery. Liposomal Bupivacaine (Exparel)
could provide good, continuous and longer pain relief than current therapies/treatments
commonly used. This can possibly improve patient satisfaction and time to normal activities
such as walking.

Inclusion Criteria:

- Patients scheduled to undergo an open or laparoscopic abdominal hernia repair.

- Ability to provide informed consent, adhere to study visit schedule, and complete all
study assessments.

Exclusion Criteria:

- Patients with a history of hypersensitivity or idiosyncratic reactions or intolerance
to any local anesthetic, opioids or ketorolac.

- Patients who abuse alcohol or other drug substance.

- Patients who are on chronic opioid therapy (taken an opioid 5 of the last 7 days).

- Patients with severe hepatic impairment.

- Patients currently pregnant.
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials